News

The Rottapharm pharmaceutical foundation buys the Bisentina island

Having sold the Bisentina island, the del Drago family gave it to the Rottapharm pharmaceutical foundation

It would be the Rottapharm pharmaceutical foundation, even if the contract would not have been finalised. Founded by will of the university professor Louis Rovati and then bought by the Swedish company Meda. The island was for about two centuries in the properties of the Drago family, the last owner of the family therefore seems to be Princess Angelica.

Roberto Pomi, 31 May 2017 – La Fune

Risultati immagini per rottapharm monzaSale of the Bisentina, the deal would seem to be closed. Last April, La Fune, relaunching an important interview conducted by Radiogiornale (the Bolsena Lake newspaper) spoke of an Italian foundation interested in purchasing.

To be exact, it was Prince Ferdinando Del Drago himself, heir to Prince Giovanni, who affirmed: “It's true, the island has been put up for sale. An Italian foundation is interested in buying”.

It would be the Rottapharm pharmaceutical foundation, even if the contract would not have been finalised. Founded by the will of the university professor Luigi Rovati and then purchased by the Swedish company Meda. The island was for about two centuries in the properties of the Drago family, the last owner of the family therefore seems to be Princess Angelica.

Again from rumors, there is talk of a figure between five and seven million euros.

Related news: History and info on the Bisentina island

Isola Bisentina, the mayors of the lake to Zingaretti: "The Region purchases and puts this place of beauty at the service"

Risultati immagini per principessa angelica del drago

Redazione Fedaiisf

Promote the cohesion and union of all members to allow a univocal and homogeneous vision of the professional problems inherent in the activity of pharmaceutical sales reps.

Articoli correlati

Back to top button
Fedaiisf Federazione delle Associazioni Italiane degli Informatori Scientifici del Farmaco e del Parafarmaco